Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

PHBV nanofiber matrices help wounds heal faster when used with hair follicle cells.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Most patients with chronic kidney disease have skin problems, which get worse as the disease progresses, and dialysis doesn't greatly reduce these issues.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Bimatoprost, a glaucoma medication, may also help treat hair loss.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

New research on prostamide F2α has led to treatments for glaucoma and eyelash growth and may have more medical uses.

FGF5s can block the effects of FGF5, which may help control hair growth in cashmere goats.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Cosmetics and procedures can cause eye issues, from mild discomfort to serious conditions, due to allergies, toxins, or poor care.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

Bimatoprost is safe and effective for improving eyebrow hair.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Hair restoration surgery has advanced, focusing on natural results and may improve further with new techniques and therapies.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Lash ptosis is more common and severe in people with congenital eyelid droop than in those with acquired eyelid droop or without eyelid droop.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.